Podcasts about neurologists

Mortgage rates are on the move once again, and if you have an ARM that is coming up on a variable rate period, it may be time to consider changing your mortgage type. The answer to knowing if you should is easier than you may think. Nate Reineke and Chelsea Jones give you the one simple step to determining what is best for you in the long run. We also answer your colleagues' questions. A Neurologist in Georgia says, “I was revisiting my retirement benefits and I forgot that I had contributed to the 457 and not the 403b because my work matches "50% of your 457 Savings Plan contributions up to 4% of your eligible pay." I feel like I should max this out as well? We took the contribution to the 457 down to 0 in our 2nd to last visit. If we do max this out, would I contribute 8% to get the maximum contribution from work of 4%?” An OBGYN in New Jersey asks, “Do I actually need life insurance?” A Double Doctor Family in Florida wants to know, “Should we have our home purchase fund invested in the stock market?” Are you ready to turn worries about taxes and investing into a plan for college and retirement? If you're evaluating your options and want to learn more, visit physicianfamily.com and click 'Get Started' or you can ask a question of your own by emailing podcast@physicianfamily.com. See marketing disclosures at physicianfamily.com/disclosures

Neurologist Dr. Majid Fotuhi, author of The Invincible Brain, joins me to break down the most powerful lifestyle habits for protecting your brain, staying sharp as you age, and reducing your risk of dementia.15 Daily Steps to Lose Weight and Prevent Disease PDF: https://bit.ly/46XTn8f - Get my FREE eBook now!Subscribe to The Genius Life on YouTube! - http://youtube.com/maxlugavereWatch my new documentary Little Empty Boxes - https://www.maxlugavere.com/filmThis episode is proudly sponsored by:Wildgrain slow-fermented sourdough and fresh pastries go from freezer to bakery-level perfection in under 25 minutes. Yum! Get $30 off your first box and free croissants in every box at Wildgrain.com/MAX or use code MAX at checkout.Fatty15 provides C15:0, a naturally occurring fatty acid found in full-fat dairy that may support cellular health and longevity—get 15% off at http://fatty15.com/MAX with code MAX!

After Deborah Kan's mother, Alvera Kan, died in December of last year, the family donated her brain to UCSF to better understand what type of dementia she had. The answer came back with not just one diagnosis, but three different types of dementia: Alzheimer's disease, vascular dementia, and LATE. Kan and her sister, Susan Whitaker, are joined by Dr. Bruce Miller, director of the UCSF Edward and Pearl Fein Memory and Aging Center, and Dr. David Soleimani-Meigooni, a neurologist at UCSF's Memory and Aging Center and assistant professor focused on precision diagnosis in Alzheimer's and related neurodegenerative diseases. Miller's work has helped shape how clinicians identify and distinguish different forms of dementia, including frontotemporal dementia, while Soleimani-Meigooni's clinical and research work includes using imaging and biomarkers to better understand amyloid, tau and other drivers of cognitive decline.In this conversation with Kan and Whitaker, Miller and Soleimani-Meigooni discuss how dementia diagnosis can remain uncertain during life and how an autopsy can reveal multiple diseases. They underscores how common mixed dementias are, why symptoms such as getting lost or struggling with numbers can point to specific brain changes, and why better diagnostic tools are needed. They also highlight the lasting scientific value of brain donation, showing how one family's decision can contribute to more precise diagnoses, better biomarkers, and, ultimately, more individualized treatment approaches for future patients.---If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

What if the guy who literally wrote the book on asset allocation told you your biggest risk isn't the market…it's the person in your bathroom mirror? Neurologist-turned-market-historian William (Bill) Bernstein joins us for a fascinating conversation about his unlikely path from photochemistry to medicine to becoming the quiet godfather of Boglehead-style investing. He shares what shaped his "simple but not easy" philosophy, why he thinks all of investing is "half math, half Shakespeare," and how a homemade website in the 1990s turned into "The Intelligent Asset Allocator" and a second career. This episode covers: ✅ How a frustrated young scientist became a neurologist, then a financial theorist and writer ✅ Early investing mistakes (Palladium futures, hot funds, overconfidence) and what finally clicked ✅ The five hurdles from If You Can and why history and psychology matter as much as math  ✅ What makes a true bubble: social buzz, career-changing speculators, hostility to skeptics, wild predictions ✅ Predictions vs forecasts, and how Bill "called" the dot-com bubble and GFC without betting the farm ✅ His current mix: modest small/value tilts, cash/T-bills for sanity, and a TIPS ladder for 30 years of expenses ✅ Why a TIPS ladder feels different from a TIPS fund and why most investors still won't use one ✅ The 30-years-working / 30-years-retired "toy model" and why it implies 20–25%+ savings rates ✅ Teaching kids about money via your own behavior, crappy college jobs, and tiny three-fund portfolios ✅ A sober view of FIRE as a way out of the cubicle and into meaningful work—not a 36-year-old beach fantasy ====================   DEALS & DISCOUNTS FROM OUR TRUSTED PARTNERS   MONARCH MONEY The modern way to manage money! Monarch will change the way you organize your financial life. Track, budget, plan, and do more with your money – together. Get 50% off the first year using this link and entering code: CATCHINGUP50   For a full list of current deals and discounts from our partners, sponsors and affiliates, click here: catchinguptofi.com/our-partners    SUPPORT  THE  SHOW

Gugs Mhlungu speaks with Dr Kirti Ranchod, Neurologist, about how our brains’ ability to store information and maintain attention is declining, the role digital devices play in this, and how activities like puzzles, colouring, crosswords, and reading can help boost cognitive health and memory. Gugs Mhlungu gets you ready for the weekend each Saturday and Sunday morning on 702. She is your weekend wake-up companion, with all you need to know for your weekend. The topics Gugs covers range from lifestyle, family, health, and fitness to books, motoring, cooking, culture, and what is happening on the weekend in 702land. Thank you for listening to a podcast from 702 Weekend Breakfast with Gugs Mhlungu. Listen live on Primedia+ on Saturdays and Sundays from 06:00 and 10:00 (SA Time) to Weekend Breakfast with Gugs Mhlungu broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/u3Sf7Zy or find all the catch-up podcasts here https://buff.ly/BIXS7AL Subscribe to the 702 daily and weekly newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden and neurologist Dr. Majid Fotuhi discuss building an "Invincible Brain." Challenging the myth that cognitive decline is inevitable, Dr. Fotuhi outlines five pillars—exercise, sleep, nutrition, stress management, and brain training, proven to increase brain volume and neuroplasticity. The discussion highlights how racket sports and balance training activate the cerebellum to boost overall function and reduce Alzheimer's risk. By consistently challenging the nervous system, you can shift the aging paradigm, achieving mental sharpness and vitality well into your 80s and 90s. This is the blueprint for lifelong brain health.     For Audience ·       Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/ !      Takeaways ·       Cognitive decline is often driven by lifestyle factors. ·       Maintaining a healthy lifestyle can mitigate cognitive decline. ·       Physical activity, especially balance training, is crucial for brain health. ·       Aging should be viewed as an opportunity for growth, not decline. ·       Trauma and psychological health significantly impact cognitive function. ·       Neuroplasticity allows the brain to change and adapt throughout life. ·       Stress management techniques can improve brain function and resilience. ·       Mindset plays a critical role in how we perceive aging and health. ·       Engaging in new activities can enhance brain health and longevity. ·       Everyone has the potential to improve their cognitive abilities at any age.       Chapters 00:00 Introduction to Cognitive Health and Aging 04:46 The Five Pillars of Brain Health 08:41 Challenging the Brain for Longevity 11:28 Mindset Shift on Aging 14:24 Reversing Cognitive Decline 19:00 Understanding Trauma and Its Impact 23:32 Healing from Psychological Trauma 24:31 Neuroplasticity and the Brain's Ability to Change 28:17 Genetics and Neurotransmitter Functionality 31:35 Mastering Stress and Achieving Flow State 32:58 Mindset and Personal Growth 37:40 Agency and Joy in Life 39:46 Understanding Glutamate and Its Effects 43:12 Rebuilding the Brain and Cognitive Improvement   To learn more about Dr. Majid Fotuhi: Website: https://biologyoftrauma.com/ Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw      Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.

Dr. Israr Ul Haq, Neurologist and Clinical Neurophysiologist at the Riverside Brain and Spine Institute, joins us to discuss signs and symptoms of Multiple Sclerosis and how neurologists diagnose and treat the condition.  Learn more about Israr Ul Haq, MD 

If you're a physician with at least 5 years of experience looking for a flexible, non-clinical, part-time medical-legal consulting role… ...Dr. Armin Feldman's Medical Legal Coaching program will guarantee to add $100K in additional income within 12 months without doing any expert witness work. Any doctor in any specialty can do this work. And if you don't reach that number, he'll work with you for free until you do, guaranteed. How can he make such a bold claim? It's simple, he gets results…  Dr. David exceeded his clinical income without sacrificing time in his full-time position. Dr. Anke retired from her practice while generating the same monthly consulting income.  And Dr. Elliott added meaningful consulting work without lowering his clinical income or job satisfaction. So, if you're a physician with 5+ years of experience and you want to find out exactly how to add $100K in additional consulting income in just 12 months, go to arminfeldman.com.                                                          =============== Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs.                                                                                                 =============== Neurologist and medical journalist Dr. Andrew Wilner shares a practical, experience-based guide to locum tenens work, based on decades of practice and long-term assignments. In this summit lecture, he explains why locums can be a powerful tool for flexibility and career control, whether you're early in practice, transitioning, or looking for a different rhythm without leaving clinical medicine. He breaks down the realities physicians often overlook until they live them: unpaid travel time, how to think about compensation beyond the daily rate, and the logistical and tax details that come with multi-state work. He also references his book on locum tenens, "The Locum Life", as a deeper resource for physicians considering this path, and answers common questions about housing, travel strategy, and walking into unfamiliar settings with confidence. You'll find links mentioned in the episode at nonclinicalphysicians.com/make-the-locum-life-better/

If you've been feeling foggy or forgetful—you might be low on Vitamin B-12. Dr. Jeanine Cook-Garard and Pandora Groth talk with Dr. Majid Fotuhi, a neurologist, and adjunct professor at the Mind Brain Institute at Johns Hopkins and at the department of Psychology and Brain Sciences at George Washington University. He is also the author of The Invincible Brain.

This episode revisits Dr. Sui Wong's insights on how the eyes are neural tissue that can reveal early signs of brain, vascular, and metabolic issues, and reframes migraine as a common, often invisible neurological condition that causes brain fog and cognitive symptoms. Actionable takeaways include scheduling regular dilated eye exams, stabilizing blood sugar, prioritizing sleep and retinal blood flow, reducing digital strain, and tracking migraine triggers to prevent worsening symptoms. In today's review of EP 342 with Dr. Sui Wong from August 2024, we cover:  • Why the eyes are considered an extension of the brain — and how the retina is neural tissue • How eye exams may provide early insight into overall neurological and vascular health • What drusen are, why small amounts can be age-related, and why monitoring retinal changes matters • The powerful idea that prevention begins before symptoms become severe • Why migraine is not “just a headache,” but a neurological condition affecting 1 in 7 people globally • The hidden symptoms of migraine — including brain fog, mood changes, word-finding difficulty, and cognitive slowing • Why migraine is a leading cause of disability in young women and often goes unrecognized • The connection between blood sugar regulation, sleep, stress, and neurological function • Practical ways to support long-term brain health through awareness, monitoring, and daily lifestyle habits • How small, consistent actions build cognitive resilience over time Welcome back to Season 15 of the Neuroscience Meets Social and Emotional Learning Podcast. I'm Andrea Samadi, and here we bridge the science behind social and emotional learning, emotional intelligence, and practical neuroscience—so we can create measurable improvements in well-being, achievement, productivity, and results. When we launched this podcast seven years ago, it was driven by a question I had never been taught to ask— not in school, not in business, and not in life: If results matter—and they matter now more than ever—how exactly are we using our brain to make these results happen? Most of us were taught what to do. Very few of us were taught how to think under pressure, how to regulate emotion, how to sustain motivation, or even how to produce consistent results without burning out. That question led me into a deep exploration of the mind–brain–results connection—and how neuroscience applies to everyday decisions, conversations, and performance. That's why this podcast exists. Each week, we bring you leading experts to break down complex science and translate it into practical strategies you can apply immediately. When the brain, body, and emotions are aligned, performance stops feeling forced—and starts to feel sustainable. Season 14 showed us what alignment looks like in real life. We looked at goals and mental direction, rewiring the brain, future-ready learning and leadership, self-leadership, which ALL led us to inner alignment. And now, Season 15 is about understanding how that alignment is built—so we can build it ourselves, using predictable, science-backed principles. Because alignment doesn't happen all at once. It happens by using a sequence. And when we understand the order of that sequence — we can replicate it. By repeating this sequence over and over again, until magically (or predictably) we notice our results have changed. Season 15 we've organized as a review roadmap, where each episode explores one foundational brain system—and each phase builds on the one before it. Season 15 Roadmap: Phase 1 — Regulation & Safety Phase 2 — Neurochemistry & Motivation Phase 3 — Movement, Learning & Cognition Phase 4 — Perception, Emotion & Social Intelligence Phase 5 — Integration, Insight & Meaning PHASE 1: REGULATION & SAFETY Staples: Sleep + Stress Regulation Core Question: Is the nervous system safe enough to learn? Anchor Episodes Episode 384[i] — Baland Jalal How learning begins: curiosity, sleep, imagination, creativity Episode 385[ii] — Bruce Perry “What happened to you?” — trauma, rhythm, relational safety Episode 387 Sui Wong Autonomic balance, lifestyle medicine, brain resilience Episode 388 Rohan Dixit HRV, real-time self-regulation, nervous system literacy Phase 1 — Regulation & Safety We have reviewed Dr. Baland Jalal where we were reminded that before learning can happen, before curiosity can emerge, before motivation or growth is possible—the brain must feel safe. Then we looked at trauma and relational safety with Dr. Bruce Perry's Book, What Happened to You, and we move onto Dr. Sui Wong, with autonomic balance, lifestyle medicine and brain resilience.

Dr Fred Wininger is a Veterinarian and Founder of the Animal Neurology Center. He joins Chris and Amy in-studio, marking a year since his practice opened in St Louis,...the only single-specialty animal hospital of its kind in the nation. He says he started as a Professor of Veterinary Medicine at Mizzou, then moved to St Louis to a multi-discipline practice. His office now deals exclusively with problems with the brain and spine in animals.

Chris and Amy welcome Dr Fred Wininger to the studio, he's opened a veterinary practice that deals with neurological issues in pets; would you date Jason Bourne?; what about the AI scams that target the elderly?; Amy has returned at the listeners are happy.

In the second installment of this three-part series, Dr. Stacey Clardy and Max Goldman discuss neuroscience research and the BRAIN Initiative.  Stay updated with everything related to Neurology on the Hill. Show transcript:  Dr. Stacey Clardy:  Hi, this is Stacey Clardy. We are going to continue with our three-part series today about the top advocacy issues covered at Neurology on the Hill 2026 in Washington, DC. Again, as many of you know, this is the AAN's annual advocacy fly-in event. Neurologists come from all over the US to Washington and meet with elected representatives to discuss issues of high importance to allow us to continue providing high-quality care to patients in the US with neurological diseases. In the first minute, we discuss the topic of Medicare, and I have with me again, Max Goldman, director of Congressional Affairs from the AAN legislative team, to talk to us about issue number two, which is neuroscience research, and specifically the BRAIN Initiative. Max, what are we going to discuss about neuroscience research? What do we need to happen in order to continue doing high-quality research? Max Goldman: So, this one is so important, and there's this wonderful program at the NIH called The BRAIN Initiative. This was founded in 2013, really reinforced in 2016 with the 21st Century Cures Act. It's just funding for basic research into how the brain works, right? And the idea behind this is that if we can understand how the brain works, we can find the next generation of treatment or cures for neurological conditions, psychiatric conditions, and issues that go through the brain. This year, we are in a precarious position. Mandatory funding for this program is expiring, and so we're going to lose a lot of money and a lot of opportunities to provide more grants to people to figure out how the brain works. So, what we are doing on Neurology on the Hill is we're asking members of Congress to support $468 million in funding in fiscal year 2027 for the BRAIN Initiative, so we can keep up the good work and keep working towards the next generation of treatments and cures for neurological conditions. Dr. Stacey Clardy: So important. Thank you, Max. To learn more about this issue and the other two issues, you can go to AAN.com. Click on advocacy. And stick with us for the third Neurology Minute, where we will get to the final issue to be discussed, telehealth. 

A doctors' union says a neurologist shortage is the perfect case study in what's going wrong across our health system. Association of Salaried Medical Specialists executive director Sarah Dalton spoke to Corin Dann.

A neurologist shares her top 5 migraine tips: track your headaches, treat early, know your triggers, limit overuse, and consider preventative medications. Sounds helpful, right? But if you've followed this exact advice and ended up with more frequent migraines, worse medication dependency, and a longer list of triggers you can't avoid, you're not alone. This episode breaks down why standard neurologist recommendations, though well-intentioned, often lead to a cycle of worsening symptoms, increased medication use, and ultimately preventative drugs. You'll learn why tracking without a real plan demoralizes you, why taking meds at the first "uh-oh moment" robs you of your body's natural resilience, why chasing triggers is a fool's errand that leaves you bubble-wrapped and anxious, and how suppressing symptoms without addressing root causes guarantees your body will fight back harder. The real answer isn't more medication or stricter trigger avoidance, it's restoring the resilience and vitality that keeps your internal needle out of the migraine zone, even in the face of stressors like sunlight, food, dehydration, or a delayed meal. If you're trapped between a rock and a hard place, white-knuckling through medication reduction, or sitting in your neurologist's office in tears because nothing is working, this episode will help you understand why the standard path fails and what you can do instead. If you're experiencing 8+ migraine days per month and ready to address the root cause instead of just managing symptoms, schedule a free consultation below: https://www.drlesliecisar.com/apply Free Training: 5 Proven Steps to Being Migraine Free (Even if you think you've already tried everything.) https://www.drlesliecisar.com/5SHMN Connect with us: Website: https://www.drlesliecisar.com/ Free Facebook Group: Healing Migraines Naturally, with Leslie Cisar, ND Ready to try something radically different that actually works? Read more about my approach here: https://www.drlesliecisar.com/map In health,Dr. Leslie Cisar

Patients say they're waiting months to see neurologists - as research shows we're facing a long-term workforce shortage. Health correspondent Kate Green reports.

There's a call for urgent government investment in specialist neurologists to treat the growing number of people with Multiple sclerosis. Amanda Rose is the National Manager at Multiple Sclerosis New Zealand, and spoke to Corin Dann.

The country has far fewer neurologists than it needs to treat conditions like Alzheimer's disease and stroke, and it's a problem that's only getting worse. Dr Anna Ranta spoke to Corin Dann.

Join Sandra and enjoy this week’s show as you listen to the medical testimony of Dr. Adam Rizvi. He discusses everything from patients staying alive with near zero blood pressure to the room darkening or brightening when a soul departs.See omnystudio.com/listener for privacy information.

Join Sandra and enjoy this week’s show as you listen to the medical testimony of Dr. Adam Rizvi. He discusses everything from patients staying alive with near zero blood pressure to the room darkening or brightening when a soul departs.See omnystudio.com/listener for privacy information.

An Auckland Neurologist says he is seeing increasing numbers of people suffering side effects from huffing nitrous oxide, with some users ingesting enormous quantities on a daily basis. Community leaders say there needs to be tighter regulation around who is able to buy and trade the product that can easily be bought in large thermos sized cannisters with the equivilent of hundreds of hits. Professor of clinical neurology at Auckland University, Dr Alan Barber spoke to Lisa Owen.

Heart health is brain health. High blood pressure, high cholesterol, and blood sugar don't just affect your heart—they can also increase stroke risk and impact memory and long-term brain function.In this episode of Baptist Health Talk, host Sandra Peebles speaks with Dr. Marcus St. John, interventional cardiologist, and Dr. Nestor Beltre, neurologist and movement disorder specialist, about how shared risk factors connect heart disease and cognitive health. They explain why keeping blood pressure in a healthy range may lower the risk of cognitive impairment, why exercise is truly “fertilizer for the brain,” and how the Mediterranean lifestyle supports both heart and brain health.The doctors also address common misconceptions about supplements and explain how stress and depression can mimic memory problems—often mistaken for early dementia. Learn practical, evidence-based steps you can take today to protect both your heart and your brain.Host:Sandra PeeblesAward-Winning JournalistGuests:Marcus St. John, M.D.Interventional CardiologistBaptist Health Miami Cardiac & Vascular InstituteNestor Beltre, M.D.Neurologist and Movement Disorders SpecialistBaptist Health Miami Neuroscience Institute

Neurologist Dr. Vinit Banga explains stress, sleep, stroke symptoms, brain health, and the effects of pollution on the brain in this powerful podcast episode with Gaurav Arora.This episode covers:•Stress symptoms and how chronic stress damages the brain•Deep sleep and why sleep is essential for brain repair•Stroke warning signs (FAST symptoms) and why minutes matter•Brain fog, memory loss, cognitive decline, early dementia signs•Delhi pollution / AQI effects on brain ageing and intelligence•Migraine triggers, headaches, and dangerous neurological red flags•Doctor-patient trust, Practo ratings, healthcare commercialization in India00:00 Impact of Delhi's Pollution on Brain Health00:37 Stress and Its Effects on Health01:39 Air Quality and Brain Aging03:24 Blood-Brain Barrier and Pollution06:03 Memory Issues and Aging07:04 Understanding Memory Formation12:20 Sleep Disorders and Brain Health13:35 The Importance of Deep Sleep16:09 Stress: The Silent Disruptor46:38 Doctor-Patient Trust and Ethical Concerns55:14 Commercialization in Healthcare01:04:15 Concluding Thoughts and GratitudeDr. Vinit Banga is Director & Head of Neurology & Neurovascular Intervention at Fortis Escorts, and shares life-saving insights on preventing stroke, protecting brain function, and understanding modern neurological risk factors.Keywords: neurologist podcast, brain health India, stress and stroke, sleep and brain, stroke symptoms, stroke warning signs, Delhi pollution brain damage, brain fog, dementia signs, migraine, Fortis neurologist, Dr Vinit Banga, Gaurav Arora podcast.#Stress #Stroke #BrainHealth #Sleep #Neurology #Podcast #DrVinitBanga

Join Jay Gunkelman (500,000+ brain scans analyzed), clinicians Joy Lunt (RN, BCN; Past President ISNR; hundreds of autism cases), Dr. Mari Swingle (author of i-Minds), John Mekrut (The Balanced Brain), Joshua Moore (MA, LMHC, BCN; Alternative Behavioral Therapy), Anthony Ramos, and host Pete Jansons for a full live Q&A on neurofeedback's impact on autism spectrum disorder—from severe non-verbal kids to life-altering changes, plus broader insights on epilepsy, sensory issues, dissociation, and more.✅ Topic 1 Explained: Neurofeedback often transforms autism symptoms (behavior, communication, family life)—~95% of Joy's cases see major gains, like one child whose school forgot his diagnosis.✅ Topic 2 Deep Dive: Not too young—even 5-year-olds benefit with careful protocols; early work prevents years of struggle by gently guiding brain development.✅ Topic 3 Insights: Intake via detailed interviews > rigid QEEG; adjust real-time based on behavior—avoid disrupting compensations for best results.✅ Additional Topics:

In this special episode, recorded live at the 2025 Genomics England Research Summit, host Adam Clatworthy is joined by parents, clinicians and researchers to explore the long, uncertain and often emotional journey to a genetic diagnosis. Together, they go behind the science to share what it means to live with uncertainty, how results like variants of uncertain significance (VUS) are experienced by families, and why communication and support matter just as much as genomic testing and research. The panel discuss the challenges families face when a diagnosis remains out of reach, the role of research in refining and revisiting results over time, and how collaboration between researchers, clinicians and participants could help shorten diagnostic journeys in the future. Joining Adam Clatworthy, Vice-Chair for the Participant Panel, on this episode are: Emma Baple – Clinical geneticist and Medical Director, South West Genomic Laboratory Hub  Jamie Ellingford – Lead genomic data scientist, Genomics England  Jo Wright – Member of the Participant Panel and Parent Representative for SWAN UK  Lisa Beaton - Member of the Participant Panel and Parent Representative for SWAN UK  Linked below are the episodes mentioned in the episode:  What is the diagnostic odyssey?  What is a Variant of Uncertain Significance?  Visit the Genomics England Research Summit website, to get your ticket to this years event. You can download the transcript, or read it below. Sharon: Hello, and welcome to Behind the Genes. My name is Sharon Jones and today we're bringing you a special episode recorded live from our Research Summit held in June this year. The episode features a panel conversation hosted by Adam Clatworthy, Vice-Chair of the Participant Panel. Our guests explore navigating the diagnostic odyssey, the often-complex journey to reaching a genetic diagnosis. If you'd like to know more about what the diagnostic odyssey is, check our bitesize explainer episode, ‘What is the Diagnostic Odyssey?' linked in the episode description. In today's episode you may hear our guests refer to ‘VUS' which stands for a variant of uncertain significance. This is when a genetic variant is identified, but its precise impact is not yet known. You can learn more about these in another one of our explainer episodes, “What is a Variant of Uncertain Significance?” And now over to Adam. -- Adam: Welcome, everyone, thanks for joining this session. I'm always really humbled by the lived experiences and the journeys behind the stories that we talk about at these conferences, so I'm really delighted to be hosting this panel session. It's taking us behind the science, it's really focusing on the people behind the data and the lived experiences of all the individuals and the families who are really navigating this system, trying to find answers and really aiming to get a diagnosis – that has to be the end goal. We know it's not the silver bullet, but it has to be the goal so that everyone can get that diagnosis and get that clarity and what this means for their medical care moving forwards.    So, today we're really going to aim to demystify what this diagnostic odyssey is, challenging the way researchers and clinicians often discuss long diagnostic journeys, and we'll really talk about the vital importance of research in improving diagnoses, discussing the challenges that limit the impact of emerging research for families on this odyssey and the opportunities for progress. So, we've got an amazing panel here. Rather than me trying to introduce you, I think it's great if you could just introduce yourselves, and Lisa, I'll start with you. Lisa: Hi, I'm Lisa Beaton and I am the parent of a child with an unknown, thought to be neuromuscular, disease. I joined the patient Participant Panel 2 years ago now and I'm also a Parent Representative for SWAN UK, which stands of Syndromes Without A Name. I have 4 children who have all come with unique and wonderful bits and pieces, but it's our daughter who's the most complicated. Adam:  Thank you. Over to you, Jo. Jo:  Hi, I'm Jo Wright, I am the parent of a child with an undiagnosed genetic condition.  So I've got an 11-year-old daughter. 100,000 Genomes gave us a VUS, which we're still trying to find the research for and sort of what I'll talk about in a bit.  And I've also got a younger daughter. I joined the Participant Panel just back in December. I'm also a Parent Rep for SWAN UK, so Lisa and I have known each other for quite a while through that. Adam:  Thank you, Jo.  And, Jamie, you're going to be covering both the research and the clinician side and you kind of wear 2 hats, so, yeah, over to you. Jamie:  Hi, everyone, so I'm Jamie Ellingford and, as Adam alluded to, I'm fortunate and I get to wear 2 hats. So, one of those hats is that I'm Lead Genomic Data Scientist for Rare Disease at Genomics England and so work as part of a really talented team of scientists and engineers to help develop our bioinformatic pipelines, so computational processes. I work as part of a team of scientists and software engineers to develop the computation pipelines that we apply at Genomics England as part of the National Health Service, so the Genomic Medicine Service that families get referred to and recruited to, and we try to develop and improve those. So that's one of my hats. And the second of those is I am a researcher, I'm an academic at the University of Manchester, and there I work really closely with some of the clinical teams in the North West to try and understand a little bit more about the functional impact of genomic variants on kind of how things happen in a cell. So, we can explore a little bit more about that but essentially, it's to provide a little bit more colour as to the impact that that genomic variant is having. Adam: Great, thank you, Jamie. Over to you, Emma. Emma: My name's Emma Baple, I'm an academic clinical geneticist in Exeter but I'm also the Medical Director of the South West genomic laboratory hub, so that's the Exeter and Bristol Genomics Laboratory. And I wear several other hats, including helping NHS England as the National Specialty Advisor for Genomics. Adam: Thank you all for being here. I think it's really important before we get into the questions just to ground ourselves in like those lived experiences that yourself and Jo and going through. So, Lisa, I'm going to start with you. The term ‘diagnostic odyssey' gets bandied around a lot, we hear about it so many times, but how does that reflect your experience that you've been through and what would you like researchers and clinicians to understand about this journey that you're on, essentially? Lisa: So I think ours is less an odyssey and more of a roller-coaster, and I say that because we sort of first started on a genetic journey, as it were, when my daughter was 9 weeks of age and she's now 16½ – the half's very important – and we still have no answers. And we've sort of come a bit backwards to this because when she was 6 months old Great Ormond Street Hospital felt very strongly that they knew exactly what was wrong with her and it was just a case of kind of confirmation by genetics. And then they sent off for a lot of different myasthenia panel genes, all of which came back negative, and so having been told, “Yes, it's definitely a myasthenia, we just need to know which one it is,” at 4 years of age that was removed and it was all of a sudden like, “Yeah, thanks, sorry.” And that was really hard actually because we felt we'd had somewhere to hang our hat and a cohort of people with very similar issues with their children, and then all of a sudden we were told, “No, no, that's not where you belong” and that was a really isolating experience. I can remember sort of saying to the neuromuscular team, “Well is it still neuromuscular in that case?” and there was a lot of shrugging of shoulders, and it just…  We felt like not only had we only just got on board the life raft, then we'd been chucked out, and we didn't even have a floaty. And in many ways I think I have made peace with the fact that we don't have a genetic diagnosis for our daughter but it doesn't get easier in that she has her own questions and my older children – one getting married in August who's already sort of said to me, you know, “Does this have implications for when we have children?”  And those are all questions I can't answer so that's really hard. Adam:  Thank you, Lisa. Yourself, Jo, how would you describe the odyssey that you're currently experiencing? Jo: So my daughter was about one when I started really noticing that she was having regressions. They were kind of there beforehand but, I really noticed them when she was one, and that's when I went to the GP and then got referred to the paediatrician. So initially we had genetic tests for things like Rett syndrome and Angelman syndrome, which they were all negative, and then we got referred on to the tertiary hospital and then went into 100,000 Genomes. So we enrolled in 100,000 Genomes at the beginning of 2017, and we got our results in April of 2020, so obviously that was quite a fraught time. Getting our results was probably not as you would want to do it because it was kind of over the phone and then a random letter. So, what I was told in that letter was that a variant of uncertain significance had been identified and they wanted to do further research to see if it might be more significant. So we were to be enrolled into another research project called Splicing and Disease, which wasn't active at the time because everything had been put on hold for COVID, but eventually we went into that. So, I didn't know what the gene was at that point, when I eventually got the form for going to get her bloods done…  So that went off and then that came back and the geneticist said, “That gives us some indication that it is significant.” So, since that point it's been trying to find more information and research to be able to make it a diagnosis. There have been 2 sort of key things that have happened towards that but we're still not there. So one of the things is that a research paper came out earlier this year so that's kind of a little bit more evidence, it's not going to give us a diagnosis but it kind of, you know, sits there. And the other thing is that my geneticist said, “Actually, yeah, it looks like it's an important change.”  That's as far as we've got. So we've still got work to do to make it a diagnosis or not.  Obviously if it is a diagnosis, it is still a one-of-a-kind diagnosis, so it doesn't give me a group to join or that kind of thing. But now I've got that research paper that I've read and read, and asked ChatGPT to verify that I've understood it right in some places, you know, with the faith that we put into ChatGPT (laughs), I've got a better understanding and I've got something now that I can look back on, the things that happened when my daughter was one, 2, 3, 4 and her development was all over the place and people thought that I was slightly crazy for the things I was saying, that “Actually, no, I can see what's happening.” So, it's like the picture's starting to come into focus but there's work to do. I haven't got a timeframe on that, I don't know when it's going to come together. And I always say that I'm a prolific stalker of the postman; ever since our first genetic tests you're just constantly waiting for the letters to drop through the door. So a diagnostic odyssey to me is just waiting for random events. Adam: I think what you've both kind of really clearly elaborated on is how you're the ones that are having to navigate this journey, you're the ones that are trying to piece this puzzle together, and the amount of time you're investing, all whilst navigating and looking after your child and trying to cope with the daily lived experience as well. And something you've both touched on that I'd love to draw out more is about how exactly was the information shared with you about the lack of diagnosis or the VUS or what's going on, because in our case you get this bit of paper through the post that has all these numbers and it's written in clinical speak and we had no conversation with the geneticist or the doctors. You see this bit of paper and you're reading it, scared for what the future will hold for your child, but I'd love to know like how were you communicated whilst all this is going on, how did you actually find out the next steps or any kind of future guidance. Lisa: So I think in our case we kept sort of going onto neuromuscular appointments, and I think for probably the first 5 years of my daughter's life I kind of had this very naïve thought that every time we turned up to an appointment it would be ‘the one' and then…   I think it would've been really helpful actually in those initial stages if they had said to us, “Actually, we don't know when this is going to happen, if it's even going to happen, you need to kind of prepare yourself for that.” It sounds fairly obvious to say but you don't know what you don't know. And in some ways we were getting genetic test results back for some really quite horrible things and they would tell us, “Oh it's good news, this mitochondrial disorder hasn't come up,” and so part of you is like, “Yay!” but then another part of you is thinking, “Well if it's not that what is it?” And we've very much kind of danced around and still don't really have an answer to whether it's life-limiting. We know it's potentially life-threatening and we have certain protocols, but even that is tricky. We live in North Yorkshire, and our local hospital are amazing. Every time we go in, if it's anything gastro-related, they say to me, “What's the protocol from Great Ormond Street?” and I say, “We don't have one” (laughs) and that always causes some fun. We try to stay out of hospitals as much as we absolutely can and do what we can at home but, equally, there's a point where, you know, we have to be guided by where we're going with her, with the path, and lots of phone calls backwards and forwards, and then is it going to be a transfer down to Great Ormond Street to manage it. And actually the way I found out that nothing had been found from 100,000 Genomes was in a passing conversation when we had been transferred down to Great Ormond Street and we'd been an inpatient for about 6 weeks and the geneticist said to me, “So obviously with you not having a diagnosis from the 100,000 Genomes…” and I said, “Sorry?  Sorry, what was that?  You've had the information back?”  And she said, “Well, yes, did nobody write to you?” and I said, “No, and clearly by my shock and surprise.” And she was a bit taken aback by that, but it happened yet again 2 years later (laughs) when she said, “Well you know everything's been reanalysed” and I said, “No.”  (Laughs)  And, so that's very much, it still feels an awful lot like I'm doing the heavy lifting because we're under lots of different teams and even when they're working at the same hospital they don't talk to each other. And I do understand that they're specialists within their own right, but nobody is really looking at my daughter holistically, and there are things that kind of interrelate across.    And at one of the talks I attended this morning they were talking about the importance of quality of life, and I think that is something that has to be so much more focused on because it's hard enough living without a diagnosis, but when you're living with a bunch of symptoms that, I think the best way I can describe it is at the moment we've got the spokes of the umbrella but we don't have the wrapper, and we don't know where we're going with it. We can't answer her questions, we can't even necessarily know that we're using the most effective treatments and therapies for her, and she's frustrated by that now, being 16, in her own right, as well as we are. And I'm panicking about the navigation towards Adult Services as well because at the minute at least we have a clinical lead in our amazing local paediatrician but of course once we hit and move into that we won't even have him and that's a really scary place to be, I think. Adam: Jo, is there anything you wanted to add on that in terms of how you've been communicated to whilst all this is going on? Jo: Yeah, so I think part of what makes it difficult is if you're across different hospitals because they're not necessarily going to see the same information. So obviously it was a bit of a different time when I got our results, but I got our results on a virtual appointment with a neurologist in one hospital, in the tertiary hospital, and because he could see the screen because it was the same hospital as genetics, and he said, “Oh you've got this” and then the letter came through later. When I had my next appointment with the neurologist in our primary hospital, or secondary care, whatever it's called, in that hospital, he hadn't seen that, so I'm telling him the results, which isn't ideal, but it happens quite a lot. What I think is quite significant to me is the reaction to that VUS.  I have to give it, the doctors that look after my daughter are brilliant, and I'm not criticising them in any way but their reaction to a VUS is “I'm so grateful for the persistence to get to a diagnosis.” Neurologists are a bit more like “Oh it's a VUS so it might be significant, it might be nothing.” Actually, as a patient, as in a parent, you actually want to know is it significant or not, “Do I look at it or not?” And, I mean, like I said, there were no research papers to look at before anyway until a few months ago so I didn't have anything to look at, but I didn't want to look at it either because you don't want to send yourself off down a path. But I think that collective sort of idea that once someone gets a VUS we need a pathway for it, “What do we do with it, what expectation do we set the patients up with and what is the pathway for actually researching further?” because this is where we really need the research. Adam:  Thank you, Jo. So, Emma, over to you in terms of how best do you think clinicians can actually support patients at navigating this odyssey and what's the difference between an initial diagnosis and a final diagnosis and how do you then communicate that effectively to the patients and their family?   Emma: So I think a key thing for me, and it's come up just now again, is that you need to remember as a doctor that the things you say at critical times in a patient's or parent's journeys they will remember – they'll remember it word for word even though you won't – and thinking about how to do that in the most sensitive, empathetic, calm, not rushed way is absolutely key.   And there are some difficulties with that when you're in a very high-pressure environment but it is absolutely crucial, that when you are communicating information about test results, when you're talking about doing the test in the first place, you're consenting the family, you're explaining what you're trying to do and those conditions, you balance how much information you give people.    So, you were talking earlier about “So you haven't got this diagnosis, you haven't got that diagnosis,” I often think it's…  We're often testing for numerous different conditions at the same time, I couldn't even list them all to the parents of the children or the patient that I'm testing. It's key to try and provide enough information without overwhelming people with so much information and information on specific conditions you are just thinking about as a potential.  Sometimes very low down your list actually but you can test for them.    Because people go home and they use the internet and they look things up and they get very, very worried about things. So, for me it's trying to provide bite-sized amounts of information, give it the time it deserves, and support people through that journey, tell them honestly what you think the chance of finding a diagnosis is. If you think it's unlikely or you think you know, sharing that information with family is helpful.   Around uncertainty, I find that a particular challenge. So, I think we've moved from a time when we used to, in this country, declare every variant we identified with an uncertain significance. Now, if we remember that we've all got 5 million variants in our genome, we've all got hundreds and hundreds… thousands and thousands, in fact, of variants of uncertain significance in our genetic code. And actually, unless you think a variant of uncertain significance genuinely does have a probability of being the cause of a child's or a patient's condition, sharing that information can be quite harmful to people.    We did a really interesting survey once when we were writing the guidelines for reporting variants of uncertain significance a few years ago. We asked the laboratories about their view of variants of uncertain significance and we asked the clinicians, and the scientists said, “We report variants of uncertain significance because the clinicians want them” and the clinicians said, “If the labs put the variant of uncertain significance on the report it must be important.” And of course, if you're a parent, if the doctor's told you the variant is a variant of uncertain significance of course you think it's important.    So, we should only be sharing that information, in my opinion, if it genuinely does have a high likelihood of being important and there are things that we can do. And taking people through that journey with you, with the degree of likelihood, the additional tests you need to do and explaining to them whether or not you think you will ever clarify that, is really, really key because it's very often that they become the diagnosis for the family.  Did I cover everything you think's important, both of you?  Lisa: I think the one thing I would say is that when you are patient- or parent-facing, the first time that you deliver that news to the parent… you may have delivered that piece of news multiple times and none of us sit there expecting you to kind of be overcome with emotion or anything like that but, in the same way that perhaps you would've had some nerves when, particularly if it was a diagnosis of something that was unpleasant, you know, to hold onto that kind of humanity and humility. Because for those patients and parents hearing that news, that is the only time they're ever hearing that, and the impact of that, and also, they're going on about with their day, you don't know what else they're doing, what they're juggling.    We're not asking you all to be responsible for kind of, you know, parcelling us up and whatnot but the way information is imparted to us is literally that thing we are all hanging our hats on, and when we're in this kind of uncertainty, from my personal experience I'm uncomfortable, I like to be able to plan, I'm a planner, I'm a researcher, I like to sort of look it up to the nth degree and that, and sitting in a place without any of that is, it's quite a difficult place to be. And it's not necessarily good news for those parents when a test comes back negative, because if it's not that then what is it, and that also leaves you feeling floundering and very isolated at times.  Adam: Yeah, and you touched upon the danger of like giving too much information or pushing families down a particular route, and then you have to pull them out of it when it's not that.   You talked about the experience you had, you felt like you'd found your home and then it's like, “Well, no, no, sorry, actually we don't think it's that.” And you've invested all of your time and your emotion into being part of that group and then you're kind of taken away again. So it's to the point where you have to be really sure before you then communicate to the families, and obviously in the meantime the families are like, “We just need to know something, we need to know,” and it's that real fine line, isn't it?    But, Jamie, over to you. Just thinking about the evolving nature of genomic diagnosis, what role does research play in refining or confirming a diagnosis over time?  Jamie: So it's really, really difficult actually to be able to kind of pinpoint one or 2 things that we could do as a community of researchers to help that journey, but perhaps I could reflect on a couple of things that I've seen happen over time which we think will improve things. And one of that's going back to the discussion that we've just had about how we classify genetic variants. And so, behind that kind of variant of uncertain significance there is a huge amount of effort and emotion from a scientist's side as well because I think many of the scientists, if not all, realise what impact that's going to have on the families.   And what we've tried to do as a community is to make sure that we are reproducible, and if you were to have your data analysed in the North West of England versus the South West that actually you'd come out with the same answer. And in order to do that we need guidance, we need recommendations, we need things that assist the scientists to actually classify those variants.  And so, what we have at the moment is a 5 point scale which ranges from benign to likely benign, variant of uncertain significance, unlikely pathogenic variant and pathogenic variant. It's objective as to how we classify a variant into one of those groups and so it's not just a gut feeling from a scientist, it's kind of recordable measurable evidence that they can provide to assist that classification.   So in many instances what that does is provide some uncertainty, as we've just heard, because it falls into that zone of variant of uncertain significance but what that also does is provide a framework in which we can generate more evidence to be able to classify it in one direction or another to become likely pathogenic or to become likely benign. And as a research community we're equipped with that understanding –– and not always with the tools but that's a developing area – to be able to do more about it.   What that doesn't mean is that if we generate that evidence that it can translate back into the clinic, and actually that's perhaps an area that we should discuss more. But kind of just generating that evidence isn't always enough and being able to have those routes to be able to translate back that into the hands of the clinicians, the clinical scientists, etc, is another challenge. Adam:  And how do you think we can drive progress in research to deliver these answers faster, to really try and shorten those diagnostic journeys, like what are the recommendations that you would say there? Jamie:  So being able to use the Genomics England data that's in the National Genomic Reference Library, as well as kind of other resources, has really transformed what we can do as researchers because it enables teams across the UK, across the world to work with data that otherwise they wouldn't be able to work with.   Behind that there's an infrastructure where if researchers find something which they think is of interest that can be reported back, it can be curated and analysed by teams at Genomics England and, where appropriate, kind of transferred to the clinical teams that have referred that family. And so having that pathway is great but there's still more that we can do about this. You know, it's reliant on things going through a very kind of fixed system and making sure that clinicians don't lose contact with families – you know, people move, they move locations, etc. And so, I think a lot of it is logistical and making sure that the right information can get to the right people, but it all falls under this kind of umbrella of being able to translate those research findings, where appropriate, into clinical reporting.   Adam:  Thank you. And, Emma, is there anything you would add in terms of like any key challenges that you think need to be overcome just to try and shorten the journeys as much as possible and find the answers to get a diagnosis?  Emma: I think trying to bridge that gap between some of the new technologies and new approaches that we've got that we can access in a research context and bringing those into diagnostics is a key area to try to reduce that diagnostic odyssey, so I really want to see the NHS continuing to support those sorts of initiatives.   We're very lucky, as Jamie said, the National Genomic Research Library has been fundamental for being able to reduce the diagnostic odyssey for large numbers of patients, not just in this country but around the world, and so trying to kind of look at how we might add additional data into the NGRL, use other research opportunities that we have in a more synergistic way with diagnostics I think is probably key to being able to do that.    We are very lucky in this country with the infrastructure that we've got and the fact that everything is so joined up. We're able to provide different opportunities in genomics for patients with rare conditions that aren't so available elsewhere in the world.  Adam: Great, thank you. I think we're it for time, so thank you very much to the panel. And I'd just say that if you do have any further questions for ourselves as participants then we're only too happy to pick those up. Thank you for lasting with us ‘til the end of the day and hope to see you soon.  -- Sharon: A huge thank you to our panel, Adam Clatworthy, Emma Baple, Jo Wright, Lisa Beaton and Jamie Ellingford, for sharing their insights and experiences. Each year at the summit, the Behind the Genes stage hosts podcast style conversations, bringing together researchers, clinicians and participants to discuss key topics in genomics.  If you're interested in attending a future Genomics England Research Summit, keep an eye out on our socials. If you'd like to hear more conversations like this, please like and subscribe to Behind the Genes on your favourite podcast app. Thank you for listening.    I've been your host, Sharon Jones. The podcast was edited by Bill Griffin at Ventoux Digital and produced by Deanna Barac.

"I have recorded over 500 deaths in my journal... and I can tell you, the room gets crowded when we pass." Join Sandra for a moving interview with Dr. Adam Rizvi, a Critical Care Physician and Neurologist who has spent decades on the frontlines of the ICU. Dr. Rizvi began keeping a "Death Journal" to process the grief of losing patients, and what he discovered changed his view of reality forever. In this episode, Dr. Rizvi shares the unexplainable phenomena he witnesses at the bedside. He tells the incredible story of a dying father whose blood pressure was so low he should have been unconscious, yet he stayed awake and conversing until the exact moment his son walked in the door. He also discusses the medical evidence for the afterlife, sharing cases where patients had zero brain activity yet woke up with clear memories of what happened. This is a powerful conversation about the "Crowded Room" phenomenon, the power of True Forgiveness to heal decades of estrangement, and the visual proof that something leaves the body when we die. In this episode: * The Death Journal: Lessons from witnessing 500+ transitions. * The Impossible Goodbye: How a dying man held on against medical odds for his son. * The "Crowded Room": Why the room feels "standing room only" when someone dies. * Visual Phenomena: Dr. Rizvi describes seeing a ball of light leave a patient's forehead. * Medical Proof: Consciousness exists even when the EEG is flat. * Healing Estrangement: A moving story of a father and daughters reuniting after 30 years. Get Dr. Adam Rizvi's book "Love Does Not Know Death": https://amzn.to/3ZjDPc9 Website: https://lovedoesnotknowdeath.com/ *Connect with Sandra Champlain: * Website (Free book by joining the 'Insiders Club, Free empowering Sunday Gatherings with medium demonstration, Mediumship Classes & more): http://wedontdie.com *Patreon (Early access, PDF of over 800 episodes & more): Visit https://www.patreon.com/wedontdieradio  *Don't miss Sandra's #1 "Best of all things afterlife related" Podcast 'Shades of the Afterlife' at https://shadesoftheafterlife.com

This episode is a continuation of my two-part interview with Professor of Neurology and author Dr. James Noble. We continue discussing his book, "Navigating Life with Dementia," how dementia is diagnosed, what can be done about it, and much more.

Welcome back to our weekend Cabral HouseCall shows!   This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track!   Check out today's questions:    Sheena: Hi Dr C! Hope you and your team are well. I've been hearing a lot about colostrum lately and it piqued my interest. Can you speak a little about it? Do you use it? Is there a brand you would recommend? Is it safe for anyone? Who should avoid it? Side effects? I take a probiotic everyday, can colostrum replace this?? Looking forward to hearing your response. Thanks in advance!                                                                                                                                                         Frankie: Hi Stephen, My name is Frankie Im 21 years old, and I wanted to follow up from Episode 3382, where you mentioned my symptoms could be connected to gut issues, low vitamin D, magnesium, metals, or GERD. Since then, I followed a strict LPR diet for about two months  no gluten, coffee, alcohol, peanuts, oats, onions, garlic, broccoli, beans, etc. My LPR symptoms improved by around 70%, and while I still have some mucus in my throat, its nowhere near as potent as before. During and after the protocol, I focused on rebuilding my gut with some gut-rebuilding supplements and slowly reintroducing foods. Its now been about three months since finishing the protocol, and Ive gained around 14 pounds. I also still deal with loose stool almost every day, which hasnt improved much. It’s honestly shocked me because Im very dialed in with both my food and workouts, yet the weight gain and digestive changes still happened. I wanted to get your thoughts on what direction to take from here. I havent run the Big 5 protocol since Im based in Canada, and it would end up costing quite a bit more with shipping and exchange rates. Also, I just wanted to mention its surprising how many young people my age are struggling with digestive and gut related issues. Its becoming way too common. Thanks again for all the work you do, and I hope you have a great day I listen to you every morning. Frankie     Gary: Hi Dr. Cabral. Im 49, male & over the last 4 years taken a deep interest in my health. I had cerebral malaria (2003) & as a result developed essential tremor both hands. Listened to 2 podcasts & working on noticeable triggers like ltd caffeine & alcohol. It hasnt got worse, but really is there any way to reverse it? Neurologist says surgery has no guarantee.  I would value the truth & if it were your wife what you would do please. So much life ahead 🙏 (PS. Partner is an IHP so DESTRESS at the heart of our approach) we want to do EVERYTHING we can. Thank you     Sienna: Hi Dr. Cabral - so excited about your new Pea Protein, got great feedback from the support team, however would love your response. Pea Protein safe for kids? Since DNS is I would approach it in same way, Dr. AI says generally kids get enough from food so not recommended… Do you give this to your daughters in same way you have it? Ie a little more protein in smoothies *daily* or just in baked goods like pancakes occasionally. Thank you! Happy holidays      Anonymous: What are some ways to improve gut motility, I'm already on a supplement program and ginger tea. Any thoughts on massage abdominal, hot stones, any other physical techniqes?     Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!      - - - Show Notes and Resources: StephenCabral.com/3634 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

My guest is a Professor of Neurology at Columbia University, and author of the book "Navigating Life with Dementia." We talk about the book, what dementia is, different types of dementia, and much more.

In this episode of the Smarter Not Harder Podcast, Dr. Melissa Jones joins Dr. Scott Sherr for an insightful and groundbreaking conversation about pediatric neurology, inflammation, and the integrative treatment of conditions like PANS, PANDAS, autism, and dysautonomia. Dr. Jones shares her journey from conventional pediatric neurology to functional and integrative care, breaking down how chronic infections, gut health, mold toxicity, and inflammation play a critical role in neuropsychiatric disorders in children — and how these issues can often be reversed. Join us as we explore: • What PANS and PANDAS really are — and why they're often misdiagnosed • Mold, mycoplasma, and Lyme: stealth infections affecting kids' brains • Why gut health, mitochondria, and detox pathways matter in autism • The power of lifestyle, sleep, diet, and supplements to reduce neuroinflammation This episode is for you if: • You're a parent or clinician curious about the root causes of neuropsychiatric symptoms • You're looking for integrative strategies to address autism, OCD, anxiety, and more • You want to understand how mold, toxins, and chronic infections impact kids' brains • You believe in treating the whole child — not just the symptoms You can also find this episode on…   YouTube: https://youtu.be/g2HDDtQGhnQ Learn more about Dr. Melissa Jones: Website: https://aiopwellness.com/ Find more from Smarter Not Harder: Website: Smarter Not Harder podcast Instagram: https://www.instagram.com/troscriptions HOMeHOPe Virtual Symposium 2026: https://homehope.org/homehope-virtual-symposium-2026 Get 10% Off your purchase of the Clinical Metabolomics module with code PODCAST10 at https://www.homehope.org/ Get 10% Off your Troscriptions purchase with code POD10 at https://www.troscriptions.com/ Get daily content from the hosts of Smarter Not Harder by following @troscriptions on Instagram.

Eye pain can be a source of serious concern for patients, bringing worries about their eyesight. While uveitis is far from the only source of ocular pain, in many presentations of the condition it is a feature. In this Editors' Choice podcast, ophthalmic surgeon Mr. Harry Petrushkin¹ ² and neurologist Dr. Ruth Dubson³ join forces to explain a comprehensive approach to uveitis treatment. Host Dr. Amy Ross Russell leads the way through a refresher on eye anatomy and the spectrum of uveitis patients neurologists are likely to encounter. These are often the more serious of patients, requiring good working relationships across disciplines. They also speak of the overlap with neuroinflammatory presentations, and the eye manifestations seen in conditions like multiple sclerosis and sarcoidosis. Read the paper: Uveitis for Neurologists (1) Uveitis and Scleritis Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK (2) Rheumatology Service, Great Ormond Street Hospital NHS Trust, London, UK (3) Blizard Institute, Queen Mary University London, London, UK Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. Production by Amy Ross Russell and Brian O'Toole. Editing by Brian O'Toole. Thank you for listening. 

You leave your neurologist's office with another prescription. You thought they'd finally dig into why you're getting migraines. Instead? Another medication to try. Here's what most people don't understand: Medical doctors aren't looking for root causes. They're confirming a diagnosis and following a checklist called "standard of care." Once the diagnosis is made, the doctor follows an algorithm: Try this medication. If that doesn't work, try this one. Keep moving down the list. They're not trained to believe your body can heal. Allopathic medicine operates from the belief that once you develop a chronic condition, it's broken and defective. You can only suppress the symptoms. But you know intuitively that if you could figure out what your body needs, it would heal. And you're right. Your body needs three things to stop generating migraines: nutrient delivery, waste clearance, and cellular resilience. The mismatch happens when you expect a root-cause investigation and get a prescription instead. If you believe your migraines can be healed, work with someone who shares that understanding. Schedule your free consultation here: https://www.drlesliecisar.com/apply Free Training: 5 Proven Steps to Being Migraine Free (Even if you think you've already tried everything.) https://www.drlesliecisar.com/5SHMN Connect with us: Website: https://www.drlesliecisar.com/ Free Facebook Group: Healing Migraines Naturally, with Leslie Cisar, ND Ready to try something radically different that actually works? Read more about my approach here: https://www.drlesliecisar.com/map

As Idahoans endure weeks of wildfire smoke each summer, a neurologist is warning that what we breathe doesn't just irritate our lungs — it may be harming our brains as well. 

Learn more about neurologist Dr. Carolyn Larkin Taylor and purchase her book, Whispers of the Mind A Neurologists Memoir at her website.Sign up for Michelle Redo's newsletter The Redo at michelleredo.comListen to more of Phil Redo's music at Bandcamp or find him on Spotify or Apple Music

Scientists are expanding our understanding of MS at an unprecedented pace. This week, Dr. Leorah Freeman discusses why, as new discoveries and medications enter clinical practice, neurologists and MS specialists should ask themselves 3 important questions when considering a patient's treatment plan. Dr. Freeman is the Director of the Multiple Sclerosis and Neuroimmunology Center at Dell Medical School at the University of Texas at Austin, where she also leads the MS and Neuroimmunology fellowship program and the MS Imaging and Outcomes Research Laboratory.  We'll also tell you about study results that reveal two distinct biologically-informed MS subtypes. We're explaining some of the confusing background to the FDA's decision not to approve a disease-modifying therapy that achieved positive results in its Phase 3 clinical trial. And did we really need a study to tell us that people living with MS fear experiencing a relapse or disease progression? Well, yes. We'll explain why. We're also reminding you to mail your insurance premium payments and other important documents earlier than you have in the past.  And we're sharing details about the two clinical trials that received $4.1 million in funding as part of the International Progressive MS Alliance Experimental Medicine Trial Awards. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: 3 questions your neurologist should be asking themselves  :22 Public Service Announcement: How the new rule about postmarks could affect your healthcare  1:16 FDA says it's not ready to approve Tolebrutinib  3:16 Study identifies two biologically-informed MS subtypes  6:29 Study results remind us that people with MS fear relapse and progression  10:09 The International Progressive MS Alliance invests $4.1 million in two clinical trials  14:04 Dr. Leorah Freeman discusses why neurologists need to ask themselves 3 important questions when considering a patient's treatment plan  17:18 Share this episode  33:16 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/436 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com The Multiple Sclerosis Insider https://themultiplesclerosisinsider.substack.com STUDY: Combined Magnetic Resonance Imaging and Serum Analysis Reveals Distinct Multiple Sclerosis Types https://academic.oup.com/brain/article/148/12/4578/8321558 STUDY: Fear of Disease Progression and Relapse in Multiple Sclerosis: A Systematic Scoping Review https://frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1680781/full JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 436 Guests: Dr. Leorah Freeman Privacy Policy

Psychologist and Neurologist, Ian Robertson, joins sean to discuss and explore a counter-intuitive idea for the new year: that boredom isn't something to fear, but something we urgently need to relearn. He argues that our constant urge to scroll and stay stimulated is eroding our ability to think, feel and create freely. Ian makes the case for boredom as a temporary relief from “mental slavery”, a state that allows the mind to wander, emotions to surface, and creativity to re-emerge.

Dr. Dean Sherzai, co-director of Loma Linda University's Alzheimer's Prevention Program, reveals how lifestyle changes can prevent up to 90% of dementias.

Dr. Derek Stitt and Drs. Joseph Safdieh and Matthew S. Robbins discuss subspecialization's impact on patient care, why preserving a core neurologist identity matters, and how training can reinforce it. Show citation: Safdieh JE, Robbins MS. Opinion & Special Articles: The Core Identity of the Neurologist. Neurology. 2025;105(9):e214265. doi:10.1212/WNL.0000000000214265 

Dr. Derek Stitt talks with Drs. Joseph Safdieh and Matthew S. Robbins about subspecialization's impact on patient care, why preserving a core neurologist identity matters, and how training can reinforce it. Read the related Resident & Fellow Section article in Neurology®. Disclosures can be found at Neurology.org. 

Drs. Greg Cooper, Natalia Rost, and Behnam Sabayan discuss preventive neurology and the need for neurologists to move beyond diagnosis and treatment toward proactive strategies for brain health.  Show citation: Sabayan B, Boden-Albala B, Rost NS. An Ounce of Prevention: The Growing Need for Preventive Neurologists. Neurology. 2025;105(1):e213785. doi:10.1212/WNL.0000000000213785 Show transcript:  Dr. Greg Cooper: Hi, this is Greg Cooper. I just finished interviewing Behnam Sabayan and Natalia Rost for this week's Neurology® Podcast. For today's Neurology Minute, I'm hoping you can tell us the main points of your paper, An Ounce of Prevention, the Growing Need for Preventative Neurologist. Dr. Behnam Sabayan: We are living in a very exciting time for the field of neurology where we are not just getting very good at diagnosis and treatment of neurological condition, but also we are stepping one step back, and that means that we will find the root causes of neurological conditions. We would act as preventive specialists and we would decrease the burden of neurological conditions, not just at the individual level, but also at the population level. And this paper calls for thinking about playing roles at different levels and stages from our offices and our rounds all the way to the community to be brain health advocates and helping other fields and disciplines to reduce the burden of neurological conditions. Dr. Greg Cooper: Well, thank you for that summary and for all of your work on this topic. Please check out this week's podcast to hear the full interview or read the full article published in Neurology®, An Ounce of Prevention: The Growing Need for Preventative Neurologists. Thank you.

Imagine sitting at home and then all of a sudden you hear a men's choir belting out “The Star Spangled Banner.” You check your phone, computer, radio. Nothing's playing. You look outside, no one's there. That's what happened to neurologist Bruce Dobkin after he received a cochlear implant. He set out to learn everything he could about the condition, called musical hallucinosis.In a story from August, Host Ira Flatow talks with Dobkin about his decision to publish his account in a medical journal and why the condition is more common than he realized.Guest: Dr. Bruce Dobkin is a neurologist at UCLA Health.Transcript is available at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Dr. Greg Cooper talks with Drs. Natalia Rost and Behnam Sabayan about the emerging field of preventive neurology, emphasizing the need for neurologists to shift from traditional diagnostic and treatment roles to a more proactive approach that includes prevention and brain health optimization.  Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Send us a textC4 Leaders – the ONLY nonprofit to utilize the pizza making process to create space for our companions to be seen, heard, and loved.   We work with businesses, sports teams, hospitals, churches…anyone looking to RISE TOGETHER.  We also write children's books and use the most amazing handmade, hand-tossed, sourdough pizza to bring out the best in each other.   Please check out c4leaders.org to support our important work. Season 5 Episode #26 Dr. Fawad Mian is coming from Denville, New Jersey (inform, inspire, & transform)You can find Dr. Mian via his website prolohealing.com or advocareneurowellnessmd.comAbout our guest: Dr. Mian is not just a physician—he is someone who's lived the very pain he now helps others overcome.  Dr. Mian is a board-certified neurologist and regenerative medicine specialist, working with active adults 55+ who are tired of being told that pills, surgery, or “just living with it” are their only options. After years of dealing with chronic pain and facing a future of invasive procedures, he chose a different path—and discovered what traditional medicine often misses: that the body can heal, when given the right tools and support.  Dr. Mian's expertise is in helping high-performing individuals reclaim their strength, mobility, and freedom through precision diagnostics, regenerative therapies like PRP and stem cells, and custom movement protocols. Dr. Mian's approach is deeply personal, because he knows what it's like to be dismissed, misdiagnosed, and stuck. That's why he treats the whole person—not just the symptom—and guides his patients with the same care he'd offer his own family.One motto at Dr. Mian's clinic is, we don't just mask pain—we resolve it. Because healing isn't a hope. It's a plan.Dr. Mian, thanks for sharing your many gifts and talents with people all over the world, thank you for seeking alternatives that help people who live with chronic pain, thank you for having the courage to write your book (Getting to Pain Free…#1 best seller on Amazon) and thanks for being our guest on Life's Essential Ingredients, welcome to the show.TOTD – “At the end of life, most of us will find that we have felt most filled up by the challenges and successful struggles for mastery, creativity, and full expression of our dharma in the world.   Fulfillment happens not in retreat from the world, but in advance – and profound engagement.”                                                                                                                       Stephen CopeBuild a habit - to create intention - to live your purpose!In this episode:What was life like growing up?What are your life's essential ingredients?Neurologist by trade…NYU for residency and Emory University for your neurophysiology/sleep medicine fellowshipStressExerciseSleepPRP after injuryDifferent treatments for joint stiffness/painChronic pain relief and IV therapySustained Energy and Focus – any supplements or even better natural ways to stay on top of your gameStem Cell TherapyGood fat vs. bad fatSkin Care Insulin Resistance and what is itIntermittent FastingElectronic devices – light exposure Congrats on your book – Getting to Pain Free #1 best seller on AmazonBooks you recommend?Legacy   

In this episode of Living Well with MS, we're sharing highlights from our Ask Aaron webinar – originally recorded as a live Overcoming MS webinar and now edited for the podcast to bring you the key insights, questions and takeaways in one place. Our guest is the dynamic and much-loved Dr Aaron Boster, a board-certified neurologist specialising in multiple sclerosis. Dr Boster answers a wide range of thoughtful, practical questions from the OvercomingMS community. From medications and MRI contrast scans to foot drop, vision changes, supplements and the latest research developments, he brings clarity, warmth and energy to every topic. If you've ever wished you could sit down with a neurologist who truly understands MS, this episode is for you. Watch this episode on YouTube. Topics and timestamps 05:08 Exciting developments in MS research 10:54 Subcutaneous injections of Ocrevus 14:27 Remyelination drug trials 22:02 Addressing fatigue in MS patients 30:14 Managing fatigue: strategies and treatments 31:04 Navigating disease-modifying therapies 31:04 Supporting loved ones with MS 35:09 Understanding MRI and gadolinium contrast 38:21 B-Cell depletion therapies and MS progression 40:42 Exploring functional mushrooms and supplements 44:35 The importance of vitamins and nutrition 52:15 Understanding neurofilament light chain 58:28 Foot drop solutions 59:29 Finding the right doctor 01:00:29 Hope for the future of MS More info and links Listen to other episodes featuring Dr Boster Check out Dr Boster's popular YouTube channel covering all aspects of MS New to Overcoming MS? Learn why lifestyle matters in MS – begin your journey at our ‘Get started' page Connect with others following Overcoming MS on the Live Well Hub Visit the Overcoming MS website Follow us on social media: Facebook Instagram YouTube Pinterest Don't miss out: Subscribe to this podcast and never miss an episode. Listen to our archive of Living Well with MS here. Make sure you sign up to our newsletter to hear our latest tips and news about living a full and happy life with MS. Support us: If you enjoy this podcast and want to help us continue creating future podcasts, please leave a donation here. Feel free to share your comments and suggestions for future guests and episode topics by emailing podcast@overcomingms.org. If you like Living Well with MS, please leave a 5-star review.

When headaches start shaping your decisions — what you say yes to, where you go, how you plan your day —they're so much more than "just a bad day." They're controlling your life. And you deserve better than living around your pain. Migraines affect 40% of the global population, yet they remain one of the most misunderstood and dismissed health conditions; many sufferers wait YEARS before seeking help, enduring an invisible illness that disrupts work, sleep, relationships, and daily routines — often without validations or answers. If you've tried everything for relief with no lasting results, this episode is for you. Recording this episode between Thanksgiving and Christmas isn't a coincidence. The holiday season—with its disrupted routines, travel stress, and dietary changes—creates the perfect storm for headaches and migraines. But these triggers aren't unique to the holidays; they show up during weddings, graduations, vacations, and any major life event. Understanding them now can help you year-round. In this episode of Get Back to Your Life®, VSI Neurologist and migraine specialist Dr. Ella Akkerman breaks down what's actually happening in your brain during a headache or migraine, why certain types require completely different treatments, and how small daily disruptions can trigger a painful cycle. Drawing on both her clinical expertise and her own experience with migraines, Dr. Akkerman offers clarity, compassion, and a realistic path to relief. You'll learn: The science behind different headache types— tension headaches, migraines, and cluster headaches—and why identifying yours changes everything How hormonal fluctuations (especially during perimenopause and menopause) can amplify migraine patterns Why the holiday season creates the "perfect storm" for headaches—and how to protect yourself Practical prevention strategies beyond medication, from hydration to stress management When it's time to see a neurologist and what treatment options actually work Whether you're dealing with occasional tension headaches or chronic migraines that disrupt your daily life, this conversation offers validation, answers, and actionable steps toward real relief. Key takeaway: You don't have to live with headaches in this era of breakthrough treatments. But the longer you wait, the harder they become to treat. If headaches are interfering with your daily life, expert help is available. Visit VSIspine.com to request an appointment with a neurologist who specializes in diagnosing and treating complex headache conditions.  Subscribe to Get Back to Your Life® for more physician-led guidance on taking control of your health.

Neurologist Carolyn Larkin Taylor discusses her article, "How medical gaslighting almost cost me my life." Carolyn shares her terrifying personal story of being dismissed by her long-time gynecologist, who labeled her cancer symptoms as "just stress." She details the frustrating journey of seeking a second opinion, the shocking discovery of her malignancy after a results mix-up, and the life-or-death stakes of the diagnostic delay. Carolyn explores the subtle, devastating impact of medical gaslighting, how it erodes a patient's reality (even when the patient is a physician), and why women's health issues are so often misdiagnosed. Learn how trusting your gut can save your life. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

A neurologist challenges Wendy Williams’ dementia diagnosis, suggesting she may not suffer from frontotemporal dementia after all. The revelation could reshape the court battle over her guardianship, a case that’s drawn national attention to elder care and financial control in celebrity health crises. See omnystudio.com/listener for privacy information.

The Rickey Smiley Morning Show dives into a whirlwind of celebrity controversy and breaking news. The crew kicks things off with Zendaya reportedly refusing to appear alongside her Euphoria co-star Sydney Sweeney, following backlash over Sweeney’s controversial “Good Jeans / Good Genes” American Eagle ad, which many deemed racially insensitive. Zendaya, known for speaking out on issues of race and representation, has drawn praise for her quiet but firm stance against what fans call “tone-deaf branding.” The conversation turns serious as a neurologist challenges Wendy Williams’ dementia diagnosis, suggesting she may not suffer from frontotemporal dementia after all. The revelation could reshape the court battle over her guardianship, a case that’s drawn national attention to elder care and financial control in celebrity health crises. Finally, the team covers Donald Trump’s ongoing legal fight, as he petitions the courts to overturn his sexual abuse and defamation verdict in the E. Jean Carroll case—an appeal many critics say leans on the influence of judges he himself appointed. Website: https://www.urban1podcasts.com/rickey-smiley-morning-show See omnystudio.com/listener for privacy information.